Correlation Analysis of DNA UGT1A1 Gene Expression in Hyperbilirubinemia and Central Nervous System-Related Adverse Reactions Following Oral Dolutegravir Administration. Medinformatics, [S. l.], v. 1, n. 1, p. 35–42, 2023. DOI: 10.47852/bonviewMEDIN32021466. Disponível em: https://ojs.bonviewpress.com/index.php/MEDIN/article/view/1466. Acesso em: 24 nov. 2024.